Crossmark

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

Crossref DOI link: https://doi.org/10.1007/s10549-015-3656-0

Published Online: 2015-12-26

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Metzger-Filho, Otto

,

de Azambuja, Evandro

Procter, Marion

Krieguer, Magalie

Smith, Ian

Baselga, Jose

Cameron, David

Untch, Michael

Jackisch, Christian

Bell, Richard

Gianni, Luca

Goldhirsch, Aron

Piccart, Martine

Gelber, Richard D.
License Information

Text and Data Mining valid from 2015-12-26